Please or to access all these features

Feminism: Sex and gender discussions

Hilary Cass sent a document to every single MP and Peer, justifying and defending the puberty blockers trial

815 replies

SingleSexSpacesInSchools · 10/07/2026 13:28

https://x.com/JamesEsses/status/2075512549248745744?s=20

There are ten images on X, sorry can't add them all here, or upload a file with it all in.

James Esses (@JamesEsses) on X

🚨Breaking🚨 Last night, in what is significant overreach for a backbench Peer, Hilary Cass sent a document to every single MP and Peer, justifying and defending the puberty blockers trial. I have posted below the full document for people to read. He...

https://x.com/JamesEsses/status/2075512549248745744?s=20

OP posts:
Thread gallery
20
noblegiraffe · 13/07/2026 00:08

AimsAndObjectives · 13/07/2026 00:05

Not yet applied for and with no obligation on current participants to take part and with no control/comparison group. It will apply to those participants who may continue to be given PBs, not to those who stop after the 1 or 2 years of the Pathways trial, so will not assess if there are longer-term harms from even short exposure.

“All participating CYP and their parents/legal guardians will be asked to assent/consent to longer term follow-up, which in the first instance will be for the life of the funding (total period 5.5 years)” page 31

AimsAndObjectives · 13/07/2026 00:07

noblegiraffe · 13/07/2026 00:02

I mean, I get that you want to nosy around the data and go ‘gosh, lots of them have mental health issues’ but on its own that tells you nothing.

Why does Cass want it then? Is she an idiot, running after crap data?

AimsAndObjectives · 13/07/2026 00:05

noblegiraffe · 12/07/2026 23:39

There are plans for a follow-up extension study into adulthood in the protocol.

Not yet applied for and with no obligation on current participants to take part and with no control/comparison group. It will apply to those participants who may continue to be given PBs, not to those who stop after the 1 or 2 years of the Pathways trial, so will not assess if there are longer-term harms from even short exposure.

noblegiraffe · 13/07/2026 00:02

I mean, I get that you want to nosy around the data and go ‘gosh, lots of them have mental health issues’ but on its own that tells you nothing.

noblegiraffe · 13/07/2026 00:00

NotBadConsidering · 12/07/2026 23:55

Wasn’t recorded? At all? In any child? Ever? Of course there will still be useful information to look at.

Recording it for some children and not for others doesn’t make it any better! Missing data is a massive problem when it comes to data analysis and wrecks the validity of conclusions.

NotBadConsidering · 12/07/2026 23:55

noblegiraffe · 12/07/2026 23:49

The notes where it wasn’t recorded if a patient had autism or childhood trauma?

What data do you think is being talked about?

Wasn’t recorded? At all? In any child? Ever? Of course there will still be useful information to look at.

noblegiraffe · 12/07/2026 23:54

ScrollingLeaves · 12/07/2026 23:48

Cass is looking for longer-term benefits and risks. This data cannot come from a 2 year trial.

In the protocol posted by noblegiraffe under Secondary Objectives it says:
To allow for future safety, efficacy, and effectiveness data, including rarer adverse effects and long-term effects, pending further funding.

Secondary Objective sounds a rather vague intention especially as, if the funding does not come through, then this objective might not be realised. The whole trial might well end up being piecemeal.

The NIHR has agreed to fund it. See page 29 of the protocol.

noblegiraffe · 12/07/2026 23:49

NotBadConsidering · 12/07/2026 23:47

Their clinical notes. From attending the clinic at the Tavistock. What do you mean “what notes”? 🙄

One of the challenges to be overcome is that NHS numbers were changed as they transitioned so in order to link the clinical records of them as children with them as adults this change in number needs to be clarified. It’s the entire point of the linkage study, to link them together and there was a change in legislation to allow research into this change in number.

The notes where it wasn’t recorded if a patient had autism or childhood trauma?

What data do you think is being talked about?

ScrollingLeaves · 12/07/2026 23:48

Cass is looking for longer-term benefits and risks. This data cannot come from a 2 year trial.

In the protocol posted by noblegiraffe under Secondary Objectives it says:
To allow for future safety, efficacy, and effectiveness data, including rarer adverse effects and long-term effects, pending further funding.

Secondary Objective sounds a rather vague intention especially as, if the funding does not come through, then this objective might not be realised. The whole trial might well end up being piecemeal.

NotBadConsidering · 12/07/2026 23:47

noblegiraffe · 12/07/2026 23:44

What notes?

Their clinical notes. From attending the clinic at the Tavistock. What do you mean “what notes”? 🙄

One of the challenges to be overcome is that NHS numbers were changed as they transitioned so in order to link the clinical records of them as children with them as adults this change in number needs to be clarified. It’s the entire point of the linkage study, to link them together and there was a change in legislation to allow research into this change in number.

NotBadConsidering · 12/07/2026 23:45

ScrollingLeaves · 12/07/2026 23:33

Thank you.
This is a screen shot for,
a) Utrecht Gender Scale
Questionnaire

https://genderanalysis.net/wp-content/uploads/2020/04/ugds-fm-mf-adolescent.png

I cannot believe that some of the statements here should relate to whether or not a girl is transgender.

“I like to behave sexually as a girl.”
What if a girl is not being sexual because she is young and has not fallen in love?

”I prefer to behave like a boy”
Good for her. Is she concentrating on maths and science? Good at a sport and keen on it? So what.

“I enjoy seeing my naked body in a mirror”
About the last thing any adolescent girl enjoys is seeing her naked body in a mirror.
Many many girls will be full of self-criticism and even possibly disgust when they look.

…. and on it goes.

This should not be serious.

I am not commenting on the boy’s as I have never been one.

And in the original Dutch research they asked the boys the boys’ questions at the start. Then at the end they asked them the girls’ questions. And vice versa.

They could have shown the same improvements in scores by just flipping it over to the other questions 5 minutes later, not PBs/CSH/surgery later.

Do we have a guarantee that this proposed trial won’t do the same?

noblegiraffe · 12/07/2026 23:44

NotBadConsidering · 12/07/2026 23:42

IF the early data is missing. If it’s not, then it’s even more useful. It’s perfectly possible to look back at the notes of children who are now adults and look for their other diagnoses.

If the linkage is allowed.

What notes?

NotBadConsidering · 12/07/2026 23:42

noblegiraffe · 12/07/2026 23:19

Your idea of useful is if it can tell us that lots of data is missing, which we already know.

IF the early data is missing. If it’s not, then it’s even more useful. It’s perfectly possible to look back at the notes of children who are now adults and look for their other diagnoses.

If the linkage is allowed.

noblegiraffe · 12/07/2026 23:39

AimsAndObjectives · 12/07/2026 23:28

Also from the Cass review:

90. When clinicians talk to patients about what interventions may be best for them, they usually refer to the longer-term benefits and risks of different options, based on outcome data from other people who have been through a similar care pathway. This information is not currently available for interventions in children and young people with gender incongruence or gender dysphoria, so young people and their families have to make decisions without an adequate picture of the potential impacts and outcomes.

91. A strand of research commissioned by the Review was a quantitative data linkage study. The aim of this study was to fill some of the gaps in follow-up data for the approximately 9,000 young people who have been through GIDS. This would help to develop a stronger evidence base about the types of support and interventions received and longer-term outcomes.

Cass is looking for longer-term benefits and risks. This data cannot come from a 2 year trial.

There are plans for a follow-up extension study into adulthood in the protocol.

ScrollingLeaves · 12/07/2026 23:33

noblegiraffe · 12/07/2026 23:00

Thank you.
This is a screen shot for,
a) Utrecht Gender Scale
Questionnaire

https://genderanalysis.net/wp-content/uploads/2020/04/ugds-fm-mf-adolescent.png

I cannot believe that some of the statements here should relate to whether or not a girl is transgender.

“I like to behave sexually as a girl.”
What if a girl is not being sexual because she is young and has not fallen in love?

”I prefer to behave like a boy”
Good for her. Is she concentrating on maths and science? Good at a sport and keen on it? So what.

“I enjoy seeing my naked body in a mirror”
About the last thing any adolescent girl enjoys is seeing her naked body in a mirror.
Many many girls will be full of self-criticism and even possibly disgust when they look.

…. and on it goes.

This should not be serious.

I am not commenting on the boy’s as I have never been one.

Hilary Cass sent a document to every single MP and Peer, justifying and defending the puberty blockers trial
AimsAndObjectives · 12/07/2026 23:28

Also from the Cass review:

90. When clinicians talk to patients about what interventions may be best for them, they usually refer to the longer-term benefits and risks of different options, based on outcome data from other people who have been through a similar care pathway. This information is not currently available for interventions in children and young people with gender incongruence or gender dysphoria, so young people and their families have to make decisions without an adequate picture of the potential impacts and outcomes.

91. A strand of research commissioned by the Review was a quantitative data linkage study. The aim of this study was to fill some of the gaps in follow-up data for the approximately 9,000 young people who have been through GIDS. This would help to develop a stronger evidence base about the types of support and interventions received and longer-term outcomes.

Cass is looking for longer-term benefits and risks. This data cannot come from a 2 year trial.

AimsAndObjectives · 12/07/2026 23:22

noblegiraffe · 12/07/2026 23:19

Your idea of useful is if it can tell us that lots of data is missing, which we already know.

Recommendation 5: NHS England, working with DHSC should direct the gender clinics to participate in the data linkage study within the lifetime of the current statutory instrument. NHS England’s Research Oversight Board should take responsibility for interpreting the findings of the research.

Why does Cass want it done, if it is so 'crap'?

noblegiraffe · 12/07/2026 23:20

BettyBooper · 12/07/2026 23:16

Any thoughts on how men saying they're women might distort data, or is that just okidowki?

Of course it isn’t.

noblegiraffe · 12/07/2026 23:19

NotBadConsidering · 12/07/2026 23:16

I have also given multiple examples of how the data could be useful and the idea of this linkage study is widely supported for these reasons.

Your idea of useful is if it can tell us that lots of data is missing, which we already know.

NotBadConsidering · 12/07/2026 23:16

noblegiraffe · 12/07/2026 23:12

If you don’t understand the difference between good data and crap data and how this affects the conclusions you can reliably draw from it then I’m not sure I can be bothered to type it out again.

I have also given multiple examples of how the data could be useful and the idea of this linkage study is widely supported for these reasons.

BettyBooper · 12/07/2026 23:16

noblegiraffe · 12/07/2026 23:12

If you don’t understand the difference between good data and crap data and how this affects the conclusions you can reliably draw from it then I’m not sure I can be bothered to type it out again.

Any thoughts on how men saying they're women might distort data, or is that just okidowki?

AimsAndObjectives · 12/07/2026 23:14

noblegiraffe · 12/07/2026 23:13

Others think that knowledge is power.

Shows how little you understand about postmodernism.

noblegiraffe · 12/07/2026 23:13

AimsAndObjectives · 12/07/2026 23:05

Not allowed pending the results of a badly conceived trial.

Others think that knowledge is power.

noblegiraffe · 12/07/2026 23:12

NotBadConsidering · 12/07/2026 23:05

You keep calling it crap data. It’s not. It’s data. It’s useful information. It’s not like there is nothing at all available from their time at the Tavistock.

If you don’t understand the difference between good data and crap data and how this affects the conclusions you can reliably draw from it then I’m not sure I can be bothered to type it out again.

AimsAndObjectives · 12/07/2026 23:11

NotBadConsidering · 12/07/2026 23:07

TRA clinicians: our patients and their parents are the ones who must decide if the benefits outweigh the risks in their particular case.

It's also worth bearing in mind that it has now been proposed by these people that there’s no such thing as a bad long term outcome, because if it’s what the child wanted at the time, and they got it, that is enough to define it as a successful outcome.

Which is more or less what they have said to Keira Bell. You wanted it. You got it. Quit moaning.